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Abstract
Neurexins (Nrxs) are presynaptic membrane proteins with a single membrane-spanning domain that mediate asymmetric
trans-synaptic cell adhesion by binding to their postsynaptic receptor neuroligins. a-Nrx has a large extracellular region
comprised of multiple copies of laminin, neurexin, sex-hormone-binding globulin (LNS) domains and epidermal growth
factor (EGF) modules, while that of b-Nrx has but a single LNS domain. It has long been known that the larger a-Nrx and the
shorter b-Nrx show distinct binding behaviors toward different isoforms/variants of neuroligins, although the underlying
mechanism has yet to be elucidated. Here, we describe the crystal structure of a fragment corresponding to the C-terminal
one-third of the Nrx1a ectodomain, consisting of LNS5-EGF3-LNS6. The 2.3 A ˚-resolution structure revealed the presence of a
domain configuration that was rigidified by inter-domain contacts, as opposed to the more common flexible ‘‘beads-on-a-
string’’ arrangement. Although the neuroligin-binding site on the LNS6 domain was completely exposed, the location of the
a-Nrx specific LNS5-EGF3 segment proved incompatible with the loop segment inserted in the B+ neuroligin variant, which
explains the variant-specific neuroligin recognition capability observed in a-Nrx. This, combined with a low-resolution
molecular envelope obtained by a single particle reconstruction performed on negatively stained full-length Nrx1a sample,
allowed us to derive a structural model of the a-Nrx ectodomain. This model will help us understand not only how the large
a-Nrx ectodomain is accommodated in the synaptic cleft, but also how the trans-synaptic adhesion mediated by a- and b-
Nrxs could differentially affect synaptic structure and function.
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Introduction
In the mammalian brain, precise synaptic connections between
billions of neurons must first be established if normal brain
functions such as perception, memory and cognition are to be
successfully executed. This requires the involvement of molecular
mechanisms that not only guide specific synaptic recognition
processes, but also allocate specific roles to each synapse during
development. Presynaptic neurexins (Nrxs) and postsynaptic
neuroligins (NLs), both of which are type I membrane proteins
containing a single-membrane spanning region, are two potential
regulators of this process since both are physically capable not only
of linking the two opposing membranes via their ectodomains, but
also of recruiting specific sets of pre- and post-synaptic proteins
near the junction [1–7]. Both the Nrx and NL gene transcripts can
be spliced alternatively at multiple sites in the ectodomain to yield
an extensive molecular diversity [8]. Furthermore, each of the
three mammalian Nrx genes (Nrx1-3) can be transcribed from two
alternative promoters, which thereby produces longer a-Nrx and
shorter b-Nrx transcripts and which results in the synthesis of
hundreds of isoforms [9]. Some type of differential interaction
between specific Nrx and NL isoforms may drive the functional
specification of each synaptic connection [4,10–12], although the
precise mechanism underlying such a process remains unknown.
The a-Nrx ectodomain is comprised of three repeats, each
containing an epidermal growth factor (EGF)-like domain flanked
by two LNS (laminin, neurexin, sex-hormone-binding globulin)
domains (also called laminin G (LG) domains) [13,14] (Fig. 1A).
Other proteins that contain this repeating unit, known as a
‘‘neurexin motif’’, include those members of the NCP (neurexin
IV/Caspr/paranodin) family that have been implicated in neuron-
glial and glial-glial interactions [15], Flamingo cadherins [16], and
crumbs (Crb) homologue proteins [17]. The shorter b-Nrx is
basically an N-terminally truncated a-Nrx, containing only the last
(6th) LNS domain at the ectodomain together with a short b-Nrx-
specific sequence at the N-terminus (Fig. 1A). Although both Nrxs
possess NL-binding activity through the common LNS6 domain
[18,19], the presence of an extra ,1,100-residue segment in a-Nrx
suggests that the latter carries out unique function(s) that cannot be
replicated by b-Nrx. In fact, some proteins bind exclusively to a-
Nrx [20,21]. In addition, one a-Nrx-specific triple knockout study
showed that a-Nrxs are specifically and uniquely required for the
correct localization of presynaptic Ca
2+ channels [22]. Despite the
‘‘extra’’ functions carried out by a-Nrx, its NL-binding specificity
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19411remains narrower than that of b-Nrx; a-Nrx can only bind NL1
isoforms lacking a 9-residue insertion at the splice site B (the ‘‘B-
variant’’), in contrast to b-Nrx which binds NL1 regardless of the
insertion [18]. As a- and b-Nrx exhibit broadly overlapping
expression patterns in the brain [13], a more complete under-
standing of the specific functional roles played by the various Nrx
isoforms in tissues is very much needed.
b-Nrx ectodomain structure equivalent to LNS6 in a-Nrx has
been extensively studied, yielding multiple crystal structures from
different subtypes (i.e., Nrx1-3), carrying different splice insertions
(SS4 + and 2), or crystallized in different conditions (e.g., presence
or absence of Ca
2+) [23–26]. Structures of the same domain in
complex with ectodomain fragments from NL1 or NL4 are also
available, providing important molecular information on the
trans-synaptic interaction that occurs between b-Nrx and NL
[27–29]. In this complex, two b-Nrx LNS6 domains indepen-
dently bind to the side of the NL dimer using their ‘‘hyper-variable
surface’’ located at the bottom of the b-sandwich fold, which
results in a unique 2:2 stoichiometry. In contrast to a wealth of
structural data on the b-Nrx described above, structural informa-
tion on a-Nrx is limited to those of the isolated LNS2 [30] and
LNS4 domains [25]. Importantly, we do not know how the LNS6
domain is organized in the context of the longer a-Nrx
ectodomain, nor do we understand the mechanism underlying
the a-Nrx-selective blockade of NL1 binding by the splice B
insertion.
In the present paper, we provide for the first time a description
of the crystal structure of an ectodomain fragment corresponding
to the third neurexin motif of bovine a-Nrx (NX1a(III)),
encompassing the domains LNS5-EGF3-LNS6. The 2.3 A ˚
resolution structure revealed the presence of unique molecular
contacts that potentially limit inter-domain mobility, thus
explaining why the B+ variant of NL1 is incompatible with a-
Nrx binding. By combining this with single-particle image analysis
using negatively stained a-Nrx1 ectodomain samples, we were able
to successfully construct a three-dimensional structural model of
the entire a-Nrx ectodomain.
Results and Discussion
The overall structure of NX1a(III)
In order to elucidate the unique NL-binding mechanism found
in a-Nrx, the structure of the LNS6 domain must be analyzed in
the context of a larger fragment, one that contains the preceding
domains at its N-terminal. As the extracellular domain of a-Nrx is
comprised of three repeating units, each containing two LNS
domains separated by an EGF-like module, we chose to use a
subfragment NX1a(III) encompassing LNS5-EGF3-LNS6 for our
structural analysis. This fragment was robustly expressed and
secreted from the transfected mammalian cells, indicating that the
truncation at the LNS4-LNS5 boundary did not have any adverse
effects on either the folding or the stability of the protein.
Furthermore, the fragment exhibited NL1-binding in a splice B-
sensitive manner (Fig. 1B), which was consistent with the results
reported by Reissner et al. [31]. The His-tagged version of the
NX1a(III) fragment was produced in Chinese hamster ovary
(CHO) lec 3.2.8.1 cells, and was then purified and crystallized.
The NX1a(III) structure, refined at 2.3 A ˚ resolution, contained
one molecule in the asymmetric unit, including the LNS5 domain
(residues 867–1045), the EGF domain (residues 1046–1084), and
the LNS6 domain (residues 1085–1261). The LNS5 and LNS6
domains formed a globular structure with dimensions measuring
Figure 1. Structural and functional overlap between a- and b-Neurexin. (A) Domain architecture. The ectodomain of a-Nrx can be divided
into three repeating units (I,III), each containing an EGF module flanked by two LNS domains. Module III corresponds to the fragment crystallized in
the current study. The LNS6 domain is followed by a linker segment of 102 residues, a transmembrane domain (TM), and a cytoplasmic tail containing
a PDZ-binding domain at the C-terminus. Locations of the five alternative splicing sites are indicated by arrows. b-Nrx shares the identical sequence
as a-Nrx after LNS6, but contains a unique segment of 37 residues at the N-terminal preceded by the signal peptide (SP). (B) NX1a(III) and NX1aEC
exhibit identical binding selectivity toward the NL1 splice variants. Binding between the Myc-tagged fragments of Nrx1a and the hGH-fusion NL1
variants were evaluated using a solid-phase binding assay followed by detection with an anti-Myc antibody. Note that all of the Nrx fragments bound
well to NL1_B2, while only the NX1b bound to NL1_B+. A major immunoreactive band of 180 kDa (indicated by an asterisk) corresponds to mouse
IgG dissociated from antibody beads.
doi:10.1371/journal.pone.0019411.g001
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elongated cylindrical structure with dimensions ,15620630 A ˚.
The central EGF domain was sandwiched between the two LNS
domains and physically separated them, thereby making the entire
molecule look like an off-centered dumbbell or ‘‘handset’’ (Fig. 2A).
Furthermore, this domain arrangement appeared to be rigidified
by the inter-domain interactions present at both ends of the EGF
domain (discussed later). The NL1-binding site of the LNS6,
located at so-called hyper-variable surface determined previously
[27–29], was completely exposed and accessible, although it was
spatially close to the LNS5 domain (Fig. 2B).
Structure of each domain
The LNS5 domain, the structure of which had never been
previously determined, adopted a 14-stranded b-sandwich fold
typical of this domain class, and showed highest similarity with the
laminin a2 LNS5 domain (1DYK) with root mean square
deviations (RMSD) of 1.55 A ˚ for the 163 matched residues. As
for the LNS6 domain, six independent crystal structures of Nrx1b,
determined either as a monomer or in complex with NL, were
available [23–29]. Each of the six structures and the corresponding
segment in the NX1a(III) structure (residues 1086–1261), proved
virtually identical (RMSD in the range of 0.36–0.72 A ˚), indicating
that the presence of extra domains at the N-terminal does not
affect the overall conformation of the LNS6 domain. However, the
trajectory of the N-terminal end differed markedly when
comparing NX1a(III) and Nrx1b. All of the Nrx1b structures
solved to date contain b-specific amino acids residues at the N-
terminal of the common G
84TTYIF sequence, which curls back
toward the top rim of the b-sandwich (Fig. 3). In contrast, the N-
terminal extension from the G
1086TTYIF sequence of the LNS6
domain in NX1a(III) emanate away from the domain almost
perpendicularly, due to a kink at Pro1085. Thus, the relative
arrangement of EGF3 and LNS6 seems to be governed by a single
Pro residue.
Figure 2. Structure of NX1a(III). (A) Two different views of the NX1a(III) structure in ribbon presentation, with the LNS5 domain colored in green,
the EGF domain in magenta, and the LNS6 domain in cyan. A Ca
2+ and an N-acetylglucosamine (GlcNac) residue attached to Asn 1186 are shown as a
yellow sphere and a stick model, respectively. (B) Molecular surface of NX1a(III) colored and viewed as in (A). Residues that constitute the NL1-binding
site in Nrx1b are colored in red. (C) Multiple-sequence alignment of LNS and EGF domains of Nrx1a. Residue numbers are based on the shortest
versions (i.e., without any splice site insertions) of the bovine Nrx1a sequence. For those domains that have structural information, secondary
structural elements are highlighted in cyan (b-strands) and red (a-helices), respectively. A segment corresponding to the inserted splicing site 1 (SS1),
which was contained in the construct used in this study but which was excluded from the numbering, is highlighted in magenta. Trp1065 in EGF3,
which plays an important role in the interdomain interaction, is highlighted in yellow. Conserved disulfide bonds are indicated by gray lines.
doi:10.1371/journal.pone.0019411.g002
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bind Ca
2+ at the hyper-variable surface of the LNS6 domain, we
found a clear electron density peak at this site. To examine the
presence of Ca
2+, we collected a diffraction data set at a
wavelength of 1.7000 A ˚ and calculated an anomalous difference
Fourier map. A robust signal stemming from an anomalous
dispersion (.4s) was observed at this site, suggesting that the
electron density entity was, in fact, Ca
2+. This site seems to be only
partially occupied, however, since the Ca
2+ had a significantly
higher B-factor value (41.6 A ˚ 2) compared with that of the
coordinated protein and water ligands (19–23 A ˚ 2). The Ca
2+
coordination assumed an octahedral geometry, as opposed to a
more typical pentagonal bipyramid [32], using two side-chain
oxygen molecules, two main-chain oxygen molecules (Asp1139,
Val1156, Ile1208, and Asn1210), and two water molecules
(Fig. 4A, right). In contrast to the LNS6 domain, no Ca
2+ was
found at the corresponding site in the LNS5 domain of NX1a(III)
(Fig. 4A, left). A clear electron density peak was found at the
corresponding site in the LNS5 domain of NX1a(III) although no
signal was observed in the anomalous difference Fourier map. In
the final model, a water molecule was assigned to this electron
density, although it could represent a Ca
2+ with very low
occupancy. In fact, amino acid residues coordinating the Ca
2+
were well conserved between the LNS5 and 6 domains. These
observations indicate that the LNS5 domain also possesses some
Ca
2+ binding capacity, although its affinity seems to be much
lower than that of the LNS6 domain. Several crystallographic
studies have shown that the occupancy of the site in Nrx1b (i.e.,
LNS6) requires the presence of Ca
2+ in the crystallization buffer,
suggesting a low affinity [23–26,28]. Furthermore, experimentally
determined Ca
2+ affinities for other LNS domains were in the
range of several hundred mM [30,33]. The partial occupancy of
the site in the crystal also suggests that the affinity was not very
high, although it was higher than those of average LNS domains.
Under physiological conditions, however, the presence of a ,mM
concentration of Ca
2+ in the extracellular milieu would enable full
occupancy of the site, thus indicating that the a- and b-Nrx
expressed on the cell surface are pre-loaded with Ca
2+ at the LNS6
domain and are ready for subsequent interaction with NLs.
Inter-domain interactions at the domain boundary of
NX1a(III)
Within the structure of NX1a(III), the central EGF3 domain
made contact with the preceding LNS5 domain and the following
LNS6 domain in unique and contrasting ways (Fig. 4B). At the
LNS5-EGF3 interface, a total of 495.6 A ˚ 2 solvent accessible surface
area (ASA) was buried by the interaction between residues from
both domains,excludingthoseinvolvedinthe directdomainlinkage
(i.e., Gly1045-Pro1046). Strikingly, this interaction was almost
exclusively mediated by Trp1065, which is located at the tip of the
C3–C4 loop (i.e., the loop between the third and the fourth Cys
among the 6 conserved cysteines in the EGF module) of the EGF3.
Theside-chainofTrp1065 wasdeeplyinserted intoa cave atthe top
of the LNS5 created by the Cys1015–Cys1043 disulfide and the
interdomain linker, resulting in numerous van der Waals contacts
and hydrogen bonds with more than 10 residues in the LNS5
domainalone (Fig.4B,left). Because ofthis extensiveinteraction,we
expected the LNS5-EGF3 junction to have only limited inter-
domain mobility. This Trp was also present in the second EGF
module (Fig. 2C), suggesting that the LNS3-EGF2 interface was
characterized by a similarly immobile nature. We searched EGF
sequences in the database for the presence of a Trp at the +4
position from the third Cys. Among the 8131 sequences classified as
‘‘EGF-like(P00008)’’ in the Pfam database, only 3.1% had this
‘‘signature Trp’’. Notably, the EGF domain sequences with this
signature are found exclusively in proteins containing the ‘‘neurexin
motif’’, which include neurexins, Caspr, Crumbs homologues, and
CELSRs (Flamingo homologues). Therefore, the Trp-mediated
intimate contact that occurs between LNS-EGF may constitute a
unique structural featureof the neurexinmotif,one that ispresentin
related membrane proteins expressed in the nervous systems.
The interdomain contact observed between the EGF3 and
LNS6 domains was similarly extensive and buried 832 A ˚ 2 of ASA,
although the nature of the interaction was drastically different
from that seen in LNS5-EGF3 (Fig. 4B, right). The interface was
relatively flat and not only involved many residues on both sides,
as opposed to the prominent contribution of Trp1065 in the ‘‘key-
in-a-hole’’-type of interaction found at the LNS5-EGF3 interface,
but was also largely hydrophilic in nature. These features point to
the possibility that the EGF3-LNS6 junction may be capable of
assuming different conformations, probably by pivoting around
the aforementioned Pro1085.
Structural model of the NX1a(III)/NL1 complex
Since a-Nrx uses the common LNS6 domain as its primary NL-
binding site [31], its binding mode should be no different from that
of b-Nrx. We confirmed this by introducing several mutations at
the putative NL-binding interface in the context of NX1a(III). As
shown in Fig. 5, mutations of the Ca
2+-coordinating residues
(D1139A and N1210A) abolished binding to the B- variant of NL1
(lanes 2 and 3). Furthermore, introduction of bulky Arg residues at
the core (i.e., S1109 or I1208), but not the periphery (D1106), of
the interface also resulted in the complete loss of binding capability
(lanes 4–6). These results strongly suggest that the same protein
Figure 3. Difference in the N-terminal trajectory of the LNS6
domain between Nrx1a and Nrx1b. Previously determined
structures of Nrx1b (PDB ID: 2R1D(green), 1C4R(yellow), 2XB6(blue)),
and the LNS6 domain of NX1a(III) (magenta) are superposed. The chain-
diverting Pro1085 in NX1a(III) is shown as a stick model.
doi:10.1371/journal.pone.0019411.g003
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However, simple superposition of the NX1a(III) structure onto the
Nrx1b/NL1 complex at the LNS6 domain was found to cause a
steric clash between LNS5 and a part of NL1 distal to the
homodimeric interface (Fig. 6A), indicating that complex forma-
tion must be accompanied by certain conformational rearrange-
ments. In order to avoid this steric clash, LNS5 should move away
from NL1. We simulated this motion by rotating the LNS5+EGF3
segment outward by 18u, using the Pro1085 at the EGF3-LNS6
junction as a pivot point (Fig. 6B). This motion opened the EGF3-
LNS6 interface and exposed the buried surfaces on each side, but
it appeared to be energetically tolerable because of the hydrophilic
nature of the exposed surface. A hinging action at the LNS5-EGF3
junction, on the other hand, seemed unfeasible since it would pull
the Trp1065 away from the cavity and at a high expenditure of
energy. Although the simulated conformational change at the
EGF3-LNS6 junction was rather large, the extent of the
movement could be made smaller if the Nrx-NL1 interface was
also rearranged. We noted significant differences among the four
independent Nrx1b/NL1 structures reported thus far, with as
much as ,8u rotational and ,2A ˚ translational deviations in the
position of Nrx relative to NL1 (Fig. 6C). This suggests that LNS6
can ‘‘sway’’ or ‘‘slide’’ to some extent while maintaining its
interaction with NL1. Consequently, this might facilitate the
binding of a-Nrx to NL even when the ideal docking orientation is
obstructed by the tip of the LNS5 domain.
The resultant structural model of the NX1a(III)/NL1 complex
also allowed us to understand the reason behind the deleterious
effect of a splice site B insertion on the NL1’s binding ability to a-
Nrx. The insertion point for the B sequence (i.e., between Glu297
and Gly 298 in NL1) is located right at the foot of the bound
LNS6, directly under the ‘‘roof’’ of the EGF3 domain (Fig. 6D).
When the B+ variant of NL1 is bound by b-Nrx, the 9-residue
loop segment is in close proximity to the bound LNS6, most likely
leaning against the convex side of the b-sandwich (Fig. 6D, dotted
line). As this segment contains an N-glycosylated Asn residue [34],
we expect the entire insertion to be highly mobile and to occlude a
significantly large space. Our model predicts that the a-Nrx
protein could barely accommodate this loop because the EGF3
was too close to the flexible insertion carrying the glycan chain,
even after the rotational rearrangement described above had been
made. Therefore, the ‘‘handset’’-like structure of NX1a(III)
explains why a-Nrx cannot bind to NL1 when the splice B
insertion is present. The potential clash between the LNS5 domain
and NL is also consistent with the reported lower affinity of a-Nrx
toward the B- variant of NL1 compared to b-Nrx.
Negative stain EM of a full-length Nrx1a ectodomain
fragment
Structural determination of the NX1a(III), which corresponded
to the core-repeating unit of the entire ectodomain, prompted us
to analyze a three-dimensional arrangement of this unit in the
Figure 4. The structures of the LNS5 and LNS6 domains. (A) Close-up views of the Ca
2+-binding pockets of LNS5 (left) and LNS6 (right). In the
LNS6 domain, a Ca
2+ (yellow sphere) is coordinated by four protein ligands and two water molecules. The same site in LNS5 is occupied by a water
molecule. (B) Inter-domain contacts at the LNS5-EGF3 (left) and EGF3-LNS6 (right) junctions. LNS domains are shown in surface rendering while the
EGF domain emerging from them is shown as a ribbon model, all colored as in Fig. 2A. Side-chains of the residues directly participating in the
interactions are represented as a stick model, and hydrogen bonds are depicted as dotted lines.
doi:10.1371/journal.pone.0019411.g004
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purified an Nrx1a fragment comprising the entire ectodomain of
bovine Nrx1a (NX1aEC, residues 1–1263) and imaged it using
negative staining electron microscopy. Each particle displayed 4 to
5 globular domains closely positioned together, which most likely
represented an individual LNS domain (Fig. 7A). Two-dimen-
sional class averages obtained from well-resolved particles revealed
several different views of the fragment, often exhibiting a ‘‘Y-
shape’’ (Fig. 7C). In most classes, however, only 4 densities were
clearly visible. The inability to visualize all six LNS domains can
be explained by the possible alignment of two or more domains
parallel to the angle of view. We then performed single-particle
reconstruction in order to deduce the three-dimensional shape of
the molecule via 2D class-averaged images. The resultant 3D
molecular envelope contained five major densities in a nonlinear
arrangement (Fig. 7D). The NX1aEC construct we used consisted
of the splice site 1+ (SS1+) form containing a 19-residue insertion
between the EGF1 and the LNS2 domains (Fig. 2C), which would
confer a high level of mobility on this domain junction. We noted
that the purified recombinant NX1aEC protein underwent
spontaneous degradation during storage due to contaminating
proteases, resulting in the production of smaller fragment
measuring ,110 kDa (Fig. 7B). By employing N-terminal Edman
sequencing of the fragment we derived a DQGKS sequence
corresponding to the last 5 residues of the SS1 insertion,
confirming the unstructured and protease-susceptible nature of
this segment. We therefore concluded that the region N-terminal
to this linker (i.e., LNS1+EGF1 domains) disappeared from the
EM class averages due to its random orientation relative to the rest
of the molecule, and that the 3D structure deduced from the single
particle reconstruction corresponded to the region encompassing
the LNS2-LNS6 segment. Recently, Nakagawa and colleagues
reported very similar negative-stain EM images of the Nrx1a
fragment [35]. Based on the results of an immunochemical
molecular labeling, they assumed that one of the two short arms of
the ‘‘Y-shape’’ corresponded to LNS6. Using this information, the
most distal domain of the Y-shape in our 3D envelope was
assigned as LNS6 and the remaining densities were assigned
consecutively based on the domain connectivity. Thus, a
molecular model of the Nrx1a ectodomain, except for the position
of the flexible LNS1+EGF1 region, was constructed by fitting the
‘‘handset’’-like structure of each LNS-EGF-LNS unit (Fig. 7E).
Model of the trans-synaptic adhesion complex formed by
a-Nrx and NL
Using the crystal structures of the 2:2 Nrx1b/NL ectodomain
complex [27–29], a model of the trans-synaptic cell adhesion
machinery in which b-Nrx and NL were engaged in a ‘‘lateral’’,
rather than a ‘‘head-on’’, fashion had been proposed [7] (Fig. 8,
far right). This model can now be extended to include a-Nrx. The
location of the NL-binding site in the membrane-proximal LNS6
domain of a-Nrx had been a puzzling problem due to the fact that
the large (,1,100 residues) membrane-distal segment must be
accommodated in the narrow space of the synaptic cleft (,20 nm).
Our structural model of the Nrx1a ectodomain clearly shows that
the N-terminal region in immediate proximity to the LNS6
domain (i.e., EGF3 and LNS5) points outward from the complex
and parallel to the membrane (Fig. 8, left). As a result, the rest of
the ectodomain projects into an open space made by the synaptic
cleft and is less likely to directly clash with the postsynaptic
membrane. This N-terminal region can serve as a docking site for
membrane proteins as well as for extracellular proteins at the
synaptic cleft, thereby increasing the complexity of the macromo-
lecular architecture of the a-Nrx-containing synapses. Further-
more, this model implies that the a- and b-Nrxs assemble adhesion
machinery quite different from one another, particularly in terms
of their lateral size, while maintaining the same membrane-to-
membrane width at the synaptic cleft. Our model predicts that the
adhesion complex made by a-Nrx/NL can be less densely
accumulated at the site of synaptic contact than that made by b-
Nrx/NL, thus limiting the ability of postsynaptic membrane
proteins such as neurotransmitter receptors to come in close
proximity to the adhesion complex. The sparse distribution of the
adhesion complex containing a-Nrx may also affect the cytoplas-
mic architecture, since the cytoplasmic tails of both adhesion
proteins contain docking sites for the scaffolding proteins [36].
Thus, the functional differentiation between the a- and b-Nrx-
containing synapses may not be solely dictated by the different NL
recognition ‘‘codes’’, but also by the difference in the adhesion
architecture, even when they are engaged by the identical NL
subtype.
Materials and Methods
Expression of Nrxs and NLs
All neurexin residue numberings are based on full-length bovine
Nrx1a without any splice site insertions (1,440 residues, assembled
from NP_776829). Expression constructs contain the entire
ectodomain (residues 1–1263, NX1aEC), the repeat III region
(residues 863–1263, NX1a(III)), or LNS6 (residues 1086–1263,
NX1b). The segments described above were PCR amplified from
pCMV-N1a-1 (a gift from T.C. Su ¨dhof) [37] and cloned in-frame
into pcDNA3.1/Myc-His (Invitrogen) that had been modified to
include a tobacco etch virus (TEV) protease cleavage site. For the
construction of NL1 expression plasmids, the ectodomain portion
of rat NL1 (residues 31–638), which contains 9 amino acid splice B
insertions, was amplified from pCMVNL1-14 (a gift from T.C.
Su ¨dhof) [37] and fused to the C-terminus of a human growth
Figure 5. NX1a(III) uses the same NL1-binding interface as
NX1b. The binding of the MycHis-tagged NX1a(III) with the indicated
mutations to the hGH_NL1_B2 was evaluated by a solid-phase binding
assay as in Figure 1B. NX1a(III) proteins bound by NL1, through the anti-
hGH beads, were visualized with a Western blot using an anti-Myc
antibody (top). The same culture supernatants were precipitated with
Ni-NTA agarose to confirm the similar expression levels of each mutant
(bottom). The migration position for the tagged NX1a(III) is indicated
with arrowheads.
doi:10.1371/journal.pone.0019411.g005
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e19411Figure 6. Structural model of the NX1a(III)/NL1 complex. (A) Simple superposition of the NX1a(III) onto the Nrx1b/NL1 heterotetramer
structure (PDB ID : 3B3Q) at the LNS6 domain, resulting in a steric clash between the LNS5 domain and the NL1 (red dotted circle). In the NX1a(III)
structure, the putative pivot point (Pro1085) and the domain-locking Trp1065 are shown as stick models. (B) Hypothetical model of the NX1a(III)/NL1
complex after simulated domain rotation. The LNS5+EGF3 segment in NX1a(III) was rotated 18u clockwise around the Pro1085, relieving the clash. (C)
The binding interface of the Nrx1b/NL1 complex demonstrates considerable plasticity. Four pairs of Nrx1b/NL1 heterodimeric complexes were
excised from the reported 2:2 complex structures (PDB ID: 3B3Q and 3BIW), and were superposed at the NL1 molecule. (D) Potential effect of splice
site B insertion in NL1 on Nrx binding. Two different views of the same structural model as in (A) are shown, with the Nrx-binding NL1 residues
painted in blue. For clarity, the LNS5 domain is omitted. The insertion point for the 9-residue splicing site B sequence (between Glu297-Gly298 in NL1,
painted in yellow) is adjacent to the interface. In the side view (lower panel), a dotted line represents the estimated route of the inserted loop
containing the bulky N-linked sugar chain.
doi:10.1371/journal.pone.0019411.g006
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resulting in the construct hGH_NL1_B+. A version that lacks
splicing B insertions was created from this construct by using
extension PCR, yielding the construct hGH_NL1_B2.
For transient expression, 293T cells were transfected with
plasmids using Fugene6 (Roche). Cell cultures were grown for
24 h, and then the culture media containing the secreted protein
was collected. For stable expression, CHOlec 3.2.8.1 cells
(provided by P. Stanley) [39] were transfected by electroporation
with a plasmid encoding NX1a(III)-MycHis, plated on 96-well
plates, and selected for resistance to 1.5 mg/ml G418. The colony
with the highest secretion level of NX1a(III)-MycHis was cultured
in roller bottles (Corning Glassworks, Corning, NY). NX1a(III)-
MycHis was purified from the culture supernatants by ammonium
sulfate precipitation and Ni-NTA affinity chromatography, treated
with histidine-tagged TEV protease, and passed through a second
Figure 7. Electron microscopic analysis of the Nrx1a ectodomain (NX1aEC). (A) A raw image of the negatively stained NX1aEC. Scale bar:
50 nm. (B) Spontaneous degradation of purified NX1aEC. SDS-PAGE analysis of NX1aEC protein immediately after purification (left) and again after 2
months storage at 4uC (right) shows that the protein undergoes proteolytic cleavage to produce N-terminal (30 kDa) and C-terminal (110-kDa)
fragments. (C) Two-dimensional class averages (upper row images) obtained from multiple electron micrographs and corresponding projection views
produced from the 3-D volume map (lower row images). Scale bar, 10 nm. (D) Three-dimensional reconstruction of the NX1aEC created from multiple
oriented particles. (E) Predicted 3D domain organization within the NX1aEC fragment. Atomic coordinates for NX1a(III) are manually fitted to the
densities corresponding to the LNS5-6 and LNS3-4 segments, keeping the C-terminus of LNS4 and the N-terminus of LNS5 close enough to be
connected. Domain connectivity was also considered when fitting the LNS2 domain structure (PDB ID: 2H0B) into the density at the bottom.
LNS1+EGF1 segment disappeared in the reconstructed volume was not assigned.
doi:10.1371/journal.pone.0019411.g007
Crystal Structure of a-Neurexin
PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e19411Ni-NTA column to remove both the cleaved MycHis tag and
the His-tagged protease. The protein was further purified by
anion-exchange chromatography using mono Q columns (GE
healthcare).
Binding assay
The binding between the Myc-tagged fragments of Nrx1a and
the hGH-fusion NL1 variants were evaluated using a solid-phase
binding assay. Briefly, hGH fusion constructs (hGH-NL1_B+,
hGH-NL1_B2, and hGH as a control) were transiently expressed
in 293T cells and the culture supernatants were incubated with
immobilized anti-hGH monoclonal antibody (clone HGH-B,
ATCC) at 4uC for 1 h to capture the fusion proteins on the
beads. After washing with 20 mM Tris (pH 8.0), 150 mM NaCl,
and 2 mM CaCl2, the beads were incubated with the culture
supernatants containing tagged Nrx constructs (NX1b-MycHis,
NX1a(III)-MycHis, NX1aEC-MycHis) and incubated at 4uC for
an additional 2 h. Bound Nrx fragments were detected by Western
blot using an anti-Myc antibody.
Crystallization, Data collection, and Structural
determination of NX1a(III)
Purified NX1a(III) was concentrated to 10 mg/ml and
subjected to crystallization screening via the hanging-drop vapor
diffusion method using a Wizard I & II screening kit (Emerald
BioSystems). The NX1a(III) crystal was grown at 20uC in hanging
drops with reservoir solution containing 0.3 M sodium malonate
(pH 7.0), 0.1 M sodium acetate, and 18% PEG 3000. Prior to data
collection, the crystals were soaked in cryoprotectant containing
0.3 M sodium malonate (pH 7.0), 0.1 M sodium acetate, 22%
PEG 3000, and 25% glycerol, and were then flash-frozen in liquid
nitrogen. Data collections were performed on SPring-8 BL-41XU,
BL-44XU, PF BL-5A and PF-AR NW12A. A diffraction data set
used for the structural determination was collected at a wavelength
of 1.0000 A ˚ using a SPring-8 BL41XU. The data set used for the
identification of Ca
2+ was collected at 1.7000 A ˚. Diffraction data
were processed with the HKL-2000 program package [40]. Initial
phases were determined via molecular replacement with MOL-
REP [41] in the CCP4 program suite [42]. The orientation and
position of LNS6 was determined by using the structure of Nrx1b
(PDB ID: 1C4R) as a search model. Subsequently, a poly-alanine
model was constructed from the Nrx1b structure and used as a
search model for LNS5. Clear solutions were obtained for both the
LNS5 and LNS6 domains. The model of EGF3 was manually
built into an electron density map calculated with the partial
structure containing LNS5 and LNS6. The resulting model was
improved by iterative cycles of manual model correction with
COOT [43] and refinement with REFMAC5 [44]. The model
was then refined at 2.3 A ˚ resolution to an R-factor of 19.7% and a
Figure 8. Schematic rendering of the Nrx1a/NL1 complex in the
synaptic cleft. Hypothetical NL1 dimer simultaneously bound by
Nrx1b and Nrx1a from opposite sides are depicted in two different
views. For Nrx1a-NL1 association, structural models of the NX1a(III)/NL1
complex (Fig. 6B) and the NX1aEC (Fig. 7E) are combined. In this
rendering, LNS1+EGF1 segment of the Nrx1a was modeled but the
position was determined arbitrary. The linker segments connecting
toward cell membrane in both proteins are represented by dotted lines.
The Nrx1/NL1 complex structure is drawn roughly in scale to the length
of the synaptic cleft (,200 A ˚).
doi:10.1371/journal.pone.0019411.g008
Table 1. Summary of data collection and refinement
statistics.
Data set Native 1 Native2
Data collection statistics
Space group P21212 P21212
Cell dimensions
a, b, c (A ˚) 72.91, 79.38, 78.14 67.92, 84.70, 77.19
X-ray source SPring-8 BL41 XU SPring-8 BL41 XU
Wavelength (A ˚) 1.00000 1.70000
Resolution (A ˚) 39.07-2.30 (2.42-2.30)* 43.69-2.40 (2.53-2.40)*
No. of reflections
Observed 147,971 (21,348)* 82,267 (11,696)*
Unique 20,732 (2,962)* 17,480 (2,549)*
Completeness (%) 99.9 (100)* 97.6 (99.4)*
Redundancy
All 7.1 (7.2)* 4.7 (4.6)*
Anomalous 2.6 (2.4)*
Rmerge 0.083 (0.271)* 0.103 (0.464)*
,I/s(I). 20.9 (6.2)* 12.9 (2.8)*
Refinement statistics
Resolution (A ˚) 39.07-2.30
No. of reflections used
Working set/test set 19,697/1,035
Rwork/Rfree 0.197/0.247
No. of atoms
Protein 3,040
Sugar 14
Ion 1
Water 148
Averaged B-factors (A ˚2)
Protein 24.28
Sugar 42.11
Ion 41.66
Water 28.34
Rmsd from ideality
Bond length (A ˚) 0.008
Bonf angles (u) 1.12
Ramachandran Plot
(MolProbity)
Favored (%) 96.44
Outlier (%) 0.25
*The numbers in parentheses are for the highest resolution shell.
doi:10.1371/journal.pone.0019411.t001
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residues, a calcium ion, and 148 water molecules. NX1a(III)
contains an N-linked glycosylation site at Asn-1186. The electron
density map revealed the presence of an N-linked glycan at Asn-
1186. The final model therefore included one N-acetylglucosa-
mine residue at this position. The quality of the final model was
validated with MolProbity [45]. 96.44% of the amino acid residues
were located in the favored region of the Ramachandran plot and
only Asn 1022 was assigned as an outlier. A summary of the data
collection and refinement statistics is shown in Table 1.
For the structural analysis, the accessible surface area was
calculated with AREAIMOL [46], and the structure superposition
was performed with SUPERPOSE [47]. Figures for protein
structures were prepared with PyMOL [48].
Electron microscopy and Image processing
A solution of purified NX1aEC was subjected to size-exclusion
chromatography on a Superdex 200 HR column immediately
before sample preparation. The peak fraction corresponding to the
monodispersed NX1aEC was negatively stained with an equal
volume of 2% uranyl acetate for 30 s. The specimen was
examined at 200 kv with a H-9500SD transmission electron
microscope (HITACHI, Tokyo, Japan). The images were
recorded on a 2K62K CCD camera (TVIPS, Gauting, Germany)
using a homemade microscope control program for spot scan at a
nominal magnification of 680,000, leading to a final image
resolution of 0.22 nm/pixel. Individual particles were boxed out
from the original images and processed using the EMAN software
suite [49] to produce 2-D class-averaged images and a 3-D
reconstruction. Visualization of the 3-D map and its projections
was performed by using Avizo (VSG, Visualization Sciences
Group, Inc.; MA, USA). Docking of the crystal structures of
NX1a(III) into the NX1aEC 3-D reconstruction was performed
using Chimera [50,51].
Accession number
The atomic coordinates of NX1a (III) have been deposited in
the Protein Data Bank with PDB ID 3ASI. The EM map of
NX1aEC has been deposited in the EMDB (www.ebi.ac.uk/msd)
with code EMD-5270.
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